際際滷shows by User: JAML10 / http://www.slideshare.net/images/logo.gif 際際滷shows by User: JAML10 / Wed, 24 Apr 2013 06:34:21 GMT 際際滷Share feed for 際際滷shows by User: JAML10 Ed 1 Apr 2013 /slideshow/ed-1-apr-2013/19890743 001013-130424063421-phpapp02
]]>
]]> Wed, 24 Apr 2013 06:34:21 GMT /slideshow/ed-1-apr-2013/19890743 JAML10@slideshare.net(JAML10) Ed 1 Apr 2013 JAML10 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/001013-130424063421-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Ed 1 Apr 2013 from Julia Laurence
]]> 787 5 https://cdn.slidesharecdn.com/ss_thumbnails/001013-130424063421-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-JAML10-48x48.jpg?cb=1591993702 Clinical trials offer treatments that fuel hope for patients who have come to the end of the road with conventional therapies and therefore the emergence of clinical trials as an option in mainstream patient healthcare. To provide a patient with access to this choice it seems obvious that a trial is opened swiftly to recruitment at the participating institution. My role of a research coordinator is pivotal to this process and I have created a financially sustainable haemato-oncology trials portfolio. As a result I have achieved various successes namely: 1. Being the first coordinator in the entire UK on 3 occasions to gain R&amp;D approvals for major commercial pharma trials 2. Dec